胰腺癌治疗和诊断市场，按类型（治疗和诊断），按地区 - 规模、份额、前景和机会分析，2022-2028

胰腺癌是在胰腺细胞中形成的癌症。 当胰腺细胞由于胰腺细胞的变化（突变）而失去控制时，就会发生胰腺癌。 这种癌症可以藉助超声波、计算机断层扫描 (CT) 扫描、磁共振成像 (MRI) 和正电子发射断层扫描 (PET) 扫描来诊断。 治疗包括手术、放射疗法、化学疗法或这些疗法的组合。

市场动态

胰腺癌发病率和患病率的上升、新治疗药物的不断开发、人口老龄化的加剧、对安全有效治疗药物的需求不断增加以及公众对胰腺癌的认识不断提高是预计增加胰腺癌发病率的主要因素胰腺癌治疗和诊断市场的增长。

例如，2021 年 1 月，Myriad Genetics Inc. 和 Illumina Inc. 联合开发了基于试剂盒的 myChoice 伴随诊断测试版本，可用于检测国际市场的胰腺癌。

此外，2020 年 9 月，印度医学研究理事会 (ICMR) - 国家癌症预防与研究所 (NICPR) 发起了一项倡议，旨在提高人们对包括胰腺癌在内的癌症的认识，主题是“印度抗癌” 。”推出 www.cancerindia.org，这是一个门户网站，提供有关印度主要癌症的信息，重点放在预防和治疗上。

这项研究的主要特点

• 本报告对全球胰腺癌治疗和诊断市场进行了深入分析，显示了以 2021 年为基准年的预测期（2022-2028 年）的市场规模和復合年增长率 (CAGR%)。 ) 提供。
• 它揭示了不同细分市场的潜在收入机会，并为该市场概述了一个有吸引力的投资建议矩阵。
• 它还提供了有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景、主要参与者采用的竞争战略等方面的重要见解。
• 根据公司亮点、产品组合、主要亮点、财务业绩和战略等参数，对全球胰腺癌治疗和诊断市场的主要参与者进行了概况分析。
• 参与这项研究的主要公司包括 F.Hoffmann-La Roche AG、Merck KgaA、Apexigen Inc.、Immunovia AB、Viatris Inc.、Amgen Inc.、AstraZeneca PLC、Bristol-Myers Squibb、Novartis AG、Pfizer Inc.、Myriad Genetics Inc.、Canon Medical Systems Corporation、FUJIFILM Holdings Corporation、波士顿科学公司和 Rafael Holdings Inc.（Rafael Pharmaceuticals）等。
• 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 本研究报告面向全球胰腺癌治疗和诊断市场的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以通过用于分析全球胰腺癌治疗和诊断市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写说明

第二章市场展望

• 报告内容
  • 市场定义和范围
• 执行摘要
  • 市场概况：按类型分类
  • 市场概况：按地区
• 连贯机会图 (COM)

第3章市场动态、规律及趋势分析

• 市场动态
  • 胰腺癌的发病率和患病率上升
  • 与诊断和治疗相关的高昂费用
  • 对安全有效的治疗药物的需求不断增加
• 影响分析
• 主要亮点
• 监管情景
• 产品发布/批准
• 害虫分析
• 对 PORTER 的分析
• 合併/收购场景

第 4 章全球胰腺癌治疗剂/诊断剂市场 - 冠状病毒 (COVID-19) 大流行的影响

• COVID-19 的流行病学特征
• 供应方和需求方分析
• 经济影响

第 5 章全球胰腺癌治疗和诊断市场：按类型，2017-2028

• 治疗药物
• 诊断

第 6 章。全球胰腺癌治疗和诊断市场：按地区划分，2017-2028

• 北美
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东和非洲
• 世界其他地区

第七章竞争格局

• F Hoffmann-La Roche AG
• Merck KgaA
• Apexigen Inc.
• Immunovia AB
• Viatris Inc.
• Amgen Inc.
• AstraZeneca PLC
• Bristol-Myers Squibb
• Novartis AG
• Pfizer Inc.
• Myriad Genetics Inc.
  • Canon Medical Systems Corporation
• FUJIFILM Holdings Corporation
• Boston Scientific Corporation
• Rafael Holdings Inc.（Rafael Pharmaceuticals）

第 8 章

• 调查方法介绍
• 关于出版商

Pancreatic cancer is cancer that forms in the cells of the pancreas. Pancreatic cancer occurs when changes (mutations) in the pancreas cells lead them to multiply out of control. The cancer can be diagnosed with the help of ultrasound, computerized tomography (CT) scans, magnetic resonance imaging (MRI) and positron emission tomography (PET) scans. Treatment may include surgery, radiation, chemotherapy, or a combination of these.

Market Dynamics:

Rise in incidence and prevalence of pancreatic cancer, rise in development of novel therapeutics, growing geriatric population, increase in demand for safe and effective therapeutics, and increase in awareness among people are major factors expected to augment growth of the global pancreatic cancer therapeutics and diagnostic market.

For instance, in January 2021, Myriad Genetics Inc. and Illumina Inc. collaborated to develop a kit-based version of the myChoice companion diagnostic test for international markets, which can be used to detect pancreatic cancer.

Moreover, in September 2020, the Indian Council of Medical Research (ICMR)-National Institute of Cancer Prevention and Research (NICPR) launched www.cancerindia.org with the theme 'India against Cancer, a portal that provides information on the leading cancers in India with the major focus on awareness, prevention, and treatment of cancers, including pancreatic cancer.

Key features of the study:

• This report provides in-depth analysis of the global pancreatic cancer therapeutics and diagnostic market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global pancreatic cancer therapeutics and diagnostic market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include F.Hoffmann-La Roche AG, Merck KgaA, Apexigen Inc., Immunovia AB, Viatris Inc., Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb, Novartis AG, Pfizer Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Boston Scientific Corporation, and Rafael Holdings Inc. (Rafael Pharmaceuticals), among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global pancreatic cancer therapeutics and diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pancreatic cancer therapeutics and diagnostic market.

Detailed Segmentation:

• Global Pancreatic Cancer Therapeutics and Diagnostic Market, By Type:
  • Treatment
  • Diagnostics
• Global Pancreatic Cancer Therapeutics and Diagnostic Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America
• Company Profiles:
  • F.Hoffmann-La Roche AG
  • Merck KgaA
  • Apexigen Inc.
  • Immunovia AB
  • Viatris Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb
  • Novartis AG
  • Pfizer Inc.
  • Myriad Genetics Inc.
  • Canon Medical Systems Corporation
  • FUJIFILM Holdings Corporation
  • Boston Scientific Corporation
  • Rafael Holdings Inc. (Rafael Pharmaceuticals)

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rise in incidence and prevalence of pancreatic cancer
  • High cost associated with diagnosis and treatments
  • Increase in demand for safe and effective therapeutics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Pancreatic Cancer Therapeutics and Diagnostic Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Pancreatic Cancer Therapeutics and Diagnostic Market, By Type, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Pancreatic Cancer Therapeutics and Diagnostic Market, By Geography, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Middle East and Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Rest of World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

7. Competitive Landscape

• F Hoffmann-La Roche AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KgaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Apexigen Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Immunovia AB
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Viatris Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Amgen Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AstraZeneca PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bristol-Myers Squibb
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Myriad Genetics Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
• Strategies
  • Canon Medical Systems Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• FUJIFILM Holdings Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Rafael Holdings Inc. (Rafael Pharmaceuticals)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

8. Section

• Research Methodology
• About us